Herb-drug interaction potential of Astragali Radix : a metabolic perspective
- 18 December 2024
- journal article
- research article
- Published by Taylor & Francis in Drug Metabolism Reviews
- p. 1-17
Abstract
Astragali Radix (AR) is one of the most widely used herbs in Asia and has a wide range of biological activities. These activities are attributed to its various compounds like flavonoids, saponins, and polysaccharides. AR and its major components are often used in combination with other drugs for the treatment of diseases such as cancer and cerebral ischemia. With the expanding range of AR combinations, the potential for herb-drug interaction (HDI) has been raised. Key targets in HDI studies include drug-metabolizing enzymes (DMEs) and transporters. Existing studies have shown that AR and its major components have various regulatory effects on these targets, notably CYP2C9, CYP3A4, UGT1A6, and P-gp. AR may contribute to HDI when it is taken with substrates of these biomolecules, such as tolbutamide, midazolam, and digoxin. However, there are also different views in the current study, such as the effect of AR on CYP3A4. To better understand the interactions of AR with drugs, we review the metabolic pathways and pharmacokinetic parameters of the main components of AR. Meanwhile, the regulatory effects and mechanisms of AR on DMEs and transporters are summarized to provide a theoretical and technical basis for the rational use of AR in clinical practice.Keywords
Funding Information
- National Key Research and Development Program of China (022YFC3501603)
- National Natural Science Foundation of China (82474177)
- Tianjin Municipal Enterprise Technology Commissioner Project (23YDTPJC00730)
This publication has 129 references indexed in Scilit:
- Simultaneous determination and pharmacokinetic study of six components in beagle dog plasma by UPLC–MS/MS after oral administration of Astragalus Membranaceus aqueous extractBiomedical Chromatography, 2022
- Phytochemistry and cardiovascular protective effects of Huang‐Qi (Astragali Radix)Medicinal Research Reviews, 2021
- Involvement of cytochrome P450 enzymes in inflammation and cancer: a reviewCancer Chemotherapy and Pharmacology, 2020
- Astragalus root extract improved average daily gain, immunity, antioxidant status and ruminal microbiota of early weaned yak calvesJournal of the Science of Food and Agriculture, 2020
- Effects of Danhong injection, a traditional Chinese medicine, on nine cytochrome P450 isoforms in vitroBiomedical Chromatography, 2018
- Interaction of soy isoflavones and their main metabolites with hOATP2B1 transporterNaunyn-Schmiedeberg's Archives of Pharmacology, 2018
- Simultaneous quantification of multiple components in rat plasma by UPLC‐MS/MS and pharmacokinetic study after oral administration of Huangqi decoctionBiomedical Chromatography, 2017
- Synergistic Effect of SH003 and Doxorubicin in Triple‐negative Breast CancerPhytotherapy Research, 2016
- Detection and identification of diterpenoid alkaloids, isoflavonoids and saponins in Qifu decoction and rat plasma by liquid chromatography–time‐of‐flight mass spectrometryBiomedical Chromatography, 2011
- Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 modelCancer Chemotherapy and Pharmacology, 2004